ABT-116 is an orally active antagonist of transient receptor potential vanilloid type 1 ( TRPV1 ). ABT-116 has analgesic efficacy. ABT-116 can be used for the research of neurological disease .
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > TRP Channel
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.